Amoytop Biotech Repurchases 7.38 Million Shares for 407 Million Yuan

财中社··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Amoytop Biotech announced on October 8 that as of September 30, 2026, the company had repurchased 7.38 million shares, accounting for 1.81% of total share capital, with a cumulative repurchase amount of 407 million yuan and a repurchase price range of 52.62 yuan to 57.2 yuan per share. In the first half of 2026, Amoytop Biotech achieved revenue of 1.837 billion yuan and net profit attributable to the parent of 477 million yuan.

Impact on assets 1

Others▲